N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide

C37H44N6O7 — CID 137338654

IUPACN-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide
SMILESCCc1c(C)cc(C(=O)N[C@H]2Cc3ccc(cc3)OCCNC(=O)C3(CC3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](C)NC2=O)c(=O)n1C
InChIInChI=1S/C37H44N6O7/c1-5-30-22(2)19-27(35(48)43(30)4)32(45)41-28-21-25-11-13-26(14-12-25)50-18-17-38-36(49)37(15-16-37)42-34(47)29(20-24-9-7-6-8-10-24)40-31(44)23(3)39-33(28)46/h6-14,19,23,28-29H,5,15-18,20-21H2,1-4H3,(H,38,49)(H,39,46)(H,40,44)(H,41,45)(H,42,47)/t23-,28-,29+/m0/s1
InChIKeyUAJIAXQOBRPPMI-WTWMYVDVSA-N
MW684.79 g/mol
LogP0.99
Rot. Bonds5

About N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide

N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide (PubChem CID 137338654) has the molecular formula C37H44N6O7 and a molecular weight of 684.79 g/mol. Its IUPAC name is N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide.

Molecular Properties

Compound NameN-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide
PubChem CID137338654
Molecular FormulaC37H44N6O7
Molecular Weight684.79 g/mol
Exact Mass684.33
IUPAC NameN-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide
SMILESCCc1c(C)cc(C(=O)N[C@H]2Cc3ccc(cc3)OCCNC(=O)C3(CC3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](C)NC2=O)c(=O)n1C
InChIInChI=1S/C37H44N6O7/c1-5-30-22(2)19-27(35(48)43(30)4)32(45)41-28-21-25-11-13-26(14-12-25)50-18-17-38-36(49)37(15-16-37)42-34(47)29(20-24-9-7-6-8-10-24)40-31(44)23(3)39-33(28)46/h6-14,19,23,28-29H,5,15-18,20-21H2,1-4H3,(H,38,49)(H,39,46)(H,40,44)(H,41,45)(H,42,47)/t23-,28-,29+/m0/s1
InChIKeyUAJIAXQOBRPPMI-WTWMYVDVSA-N
XLogP0.99
TPSA176.73 Ų
H-Bond Donors5
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms50
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500684.79
LogP ≤ 50.99
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'crown_ether', 'substructure': 'N/A'}

Analyze N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide?
The IUPAC name of N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide (CID 137338654) is N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide.
What is the SMILES notation for N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide?
The canonical SMILES for N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide is CCc1c(C)cc(C(=O)N[C@H]2Cc3ccc(cc3)OCCNC(=O)C3(CC3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](C)NC2=O)c(=O)n1C.
What is the InChIKey of N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide?
The InChIKey is UAJIAXQOBRPPMI-WTWMYVDVSA-N. The full InChI is InChI=1S/C37H44N6O7/c1-5-30-22(2)19-27(35(48)43(30)4)32(45)41-28-21-25-11-13-26(14-12-25)50-18-17-38-36(49)37(15-16-37)42-34(47)29(20-24-9-7-6-8-10-24)40-31(44)23(3)39-33(28)46/h6-14,19,23,28-29H,5,15-18,20-21H2,1-4H3,(H,38,49)(H,39,46)(H,40,44)(H,41,45)(H,42,47)/t23-,28-,29+/m0/s1.
What are the key properties of N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide?
N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide has a molecular weight of 684.79 g/mol, XLogP of 0.99, 5 rotatable bonds, 5 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(10R,13S,16S)-10-benzyl-13-methyl-6,9,12,15-tetraoxospiro[2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-triene-7,1'-cyclopropane]-16-yl]-6-ethyl-1,5-dimethyl-2-oxopyridine-3-carboxamide is sourced from PubChem (CID 137338654), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).